Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV (Q84509129)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 2010

Language	Label	Description	Also known as
English	Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV	scientific article published on 01 July 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus macaques with RT-SHIV (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Antonia Radaelli

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Mélanie Caron

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Guillaume Besson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sonia Lekana-Douki Etenna

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Armel Mintsa-Ndong

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Spyridon Mourtas

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Carlo De Giuli Morghen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Roberta Loddo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Paolo La Colla

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sophia G Antimisiaris

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mirdad Kazanji

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

405

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

225-233

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Dawn of non-nucleoside inhibitor-based anti-HIV microbicides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

HIV vaccines: new frontiers in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

The role of sexually transmitted diseases in HIV transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

In vitro microbicidal activity of the nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 against NNRTI-resistant human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Medicine. The need for a global HIV vaccine enterprise

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Cyclodextrins in topical drug formulations: theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Progesterone implants enhance SIV vaginal transmission and early virus load

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Microbicides: a new frontier in HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

HIV co-receptors as targets for antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Inhibiting sexual transmission of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Better Protective Effects in Rhesus Macaques by Combining Systemic and Mucosal Application of a Dual Component Vector Vaccine After Rectal SHIV89.6P Challenge Compared to Systemic Vaccination Alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Microbicides: a new approach to preventing HIV and other sexually transmitted infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2010.06.008

7 January 2021

Identifiers

10.1016/J.VIROL.2010.06.008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20591460%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84509129&oldid=1369554908"